Microchip Technology Incorporated (MCHP) Income Statement

The revenue trajectory shows a clear V-shaped recovery, with sequential growth accelerating from -2.0% in 2026Q2 to +13.2% in 2027Q1. This suggests the destocking cycle has ended and broad-based demand is returning, likely driven by industrial and automotive end-markets. However, the sustainability of this growth depends on whether it reflects genuine end-demand or channel restocking, which warrants monitoring of sell-through data.

The 11.6 percentage point expansion in gross margin over five quarters underscores the high fixed-cost nature of MCHP's internal fabs. As revenue scales, under-utilization charges dissipate, driving margin recovery. However, the current 63.2% gross margin is still below historical peaks of 60%+ during strong demand periods, suggesting there may be room for further improvement if the recovery persists, but also highlighting sensitivity to any demand hiccup.

The dramatic swing in operating margin from -10.3% to 22.7% within five quarters illustrates the power of operating leverage in a high-fixed-cost model. R&D and SG&A expenses grew only modestly (from $407M to $493M combined) while revenue nearly doubled, allowing incremental revenue to flow through to operating income. This suggests that if revenue continues to grow, operating margins could approach or exceed pre-downturn levels, but the pace of SG&A growth relative to revenue will be key.

The cost structure shows that MCHP has maintained tight control over operating expenses during the downturn, with R&D and SG&A growing at a slower pace than revenue. This discipline is crucial for margin recovery. However, R&D spending as a percentage of revenue has declined from 26% in 2025Q4 to 20.8% in 2027Q1, which could signal underinvestment in future product development if sustained, though it may be a temporary effect of revenue rebound.